Qilu Pharmaceutical Co., Ltd design mark 016071491
"Design mark 016071491" is a figurative mark owned by Qilu Pharmaceutical Co., Ltd, filed at the EUIPO on November 21, 2016. It is registered and covers classes 1, 5, 10, 42 and 44.
- Status
- Registered
- Since March 24, 2017
- Filed
- November 21, 2016
- Registered
- March 22, 2017
- Expires
- November 21, 2036
- Application no.
- 016071491
- Registration no.
- 016071491
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Figurative mark
- 5 classes
Who owns Qilu Pharmaceutical Co., Ltd design mark 016071491
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Qilu Pharmaceutical Co., Ltd
Representative
Abg Intellectual Property
Abg Intellectual Property
What the mark covers
The products and services Qilu Pharmaceutical Co., Ltd design mark 016071491 is filed for, grouped by Nice class.
Chemicals used in industry; chemicals for science; Chemicals used in photography; Chemicals for use in agriculture; horticulture chemicals; Chemicals used in forestry; Unprocessed artificial resins; Unprocessed plastics; Manures; Fire extinguishing compositions; Metal tempering preparations; Soldering preparations; Chemical substances for preserving foodstuffs; Tanning substances; Adhesives used in industry; Active chemical ingredients for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemical preparations for use in the manufacture of pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals; Chemical substances for use in the manufacture of pharmaceuticals; chemical reagents for use in genetic research
Pharmaceuticals; Veterinary preparations; Sanitary preparations for medical purposes; Foodstuffs and dietetic substances for medical or veterinary purposes; Baby food; Dietary supplements for humans and animals; Plasters, materials for dressings; Material for stopping teeth, dental wax; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides; Chemical preparations for pharmaceutical purposes; Chemical preparations for veterinary purposes; Chemical preparations for medical purposes; Active pharmaceutical ingredients; Hormones for medical purposes; Steroids; Chemico-pharmaceutical preparations; Antihistamines; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Blood for medical purposes; Blood plasma; Bracelets for medical purposes; Contact lens cleaning preparations; Dental abrasives; Solutions for contact lenses; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprised of living tissues; Medicine; Cachets for pharmaceutical purposes; Drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations
Surgical apparatus and instruments; Medical apparatus and instruments; Dental apparatus and instruments; Veterinary apparatus and instruments; Artificial limbs; Artificial eyes; Artificial teeth; Orthopedic articles; Suture materials; Injection syringes; Injection devices for pharmaceuticals; Surgical implants [artificial materials]
Scientific and technological services and research and design relating thereto; industry analysis and research services; Design and development of computer hardware and software; Pharmaceutical research and development; Provision of information and data relating to medical and veterinary research and development; Conducting clinical trials for pharmaceutical products; Analytical laboratory services; Scientific research relating to genetics; Analysis and evaluation of product development; Design and development of new technology for others; Information, advisory and consultancy services relating to all of the aforementioned services
Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2018/200 Section C.2.1
- Bulletin 2017/058 Section B.1
- Bulletin 2016/236 Section A.1
About Qilu Pharmaceutical Co., Ltd design mark 016071491
Who owns the trademark "Design mark 016071491"?
The EUIPO trademark "Design mark 016071491" (application 016071491) is owned by Qilu Pharmaceutical Co., Ltd.
What is the status of "Design mark 016071491"?
Its status at the EUIPO is: registered.
When was "Design mark 016071491" registered?
It was registered on March 22, 2017 and is due to expire on November 21, 2036.
Get this data via the API
Everything on this page comes from the Signa API. Pull Qilu Pharmaceutical Co., Ltd design mark 016071491 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d4291-ed63-75ef-8432-bb3c7168ca9b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d4291-ed63-75ef-8432-bb3c7168ca9b",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "016071491",
"filing_date": "2016-11-21",
"nice_classes": [
1,
5,
10,
42,
44
],
"owners": [
{
"name": "QILU PHARMACEUTICAL CO., LTD",
"entity_id": "ent_019ebad2-e6ed-741e-80d6-97b414416474"
}
]
}